Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today shared updates from its clinical programs focused on limb-girdle muscular dystrophy (LGMD) subtypes 2C/R5 ...

The first quarter started positively, with several customer projects from the 150-strong pipeline moving closer to ramp-up and commercial phase. The Advanced segment showed strong momentum during the ...

The approval is primarily based on the results from JUPITER-02 (NCT03581786), the first international multi-center, double-blind, randomized Phase 3 clinical study in NPC immunotherapy with the ...

Bhageerath Bogi epitomizes the perfect blend of technical mastery and strategic leadership in the arenas of applied AI and data science.

today announced that it will host a virtual investor event on April 29 th at 8:00 a.m. ET to review key pipeline updates in conjunction with the 2025 American Association for Cancer Research (AACR ...

today announced that it will host a virtual investor event on April 29 th at 8:00 a.m. ET to review key pipeline updates in conjunction with the 2025 American Association for Cancer Research (AACR) ...

Data for ABBV-969, a novel STEAP1/PSMA dual-targeted antibody-drug conjugate (ADC) in Phase 1 for advanced prostate cancer, will be presented in an oral presentation. Data to be presented on ABBV ...

After being indefinitely suspended in the first days of the Trump administration, key National Institutes of Health committees that approve research grants resumed meeting this week. It appears to ...

Additional presentations at the AACR annual meeting will include real-world-data analyses in two key areas of cancer research - treatment resistance and biomarker discovery: Further information ...

Enbridge has pitched the planned Line 5 tunnel underneath the Straits of Mackinac as a way to avoid oil spills. Six Michigan tribes are pulling out of a lengthy federal review process for a ...